Skip to main content
Premium Trial:

Request an Annual Quote

Mesa Biotech COVID-19 Test Receives FDA Emergency Use Authorization

NEW YORK – Mesa Biotech said on Tuesday that it has received Emergency Use Authorization from the US Food and Drug Administration for its Accula SARS-CoV-2 test.

The PCR test is designed for the qualitative visual detection of nucleic acid from the SARS-CoV-2 virus in combined throat swab and nasal swab specimens from patients suspected by their healthcare provider of having COVID-19.

The 30-minute assay, read visually, uses the company's Accula system, which is designed for point-of-care use, for example in screening facilities, physician office labs, urgent care centers, or long-term nursing facilities. "Our test will provide a highly accessible means for healthcare professionals to access laboratory-quality results close in their office to aid in the decision to isolate, treat, or dismiss potential carriers of the virus," said Mesa Biotech Cofounder and CEO Hong Cai in a statement.

Mesa Biotech has been working on clinically validating its COVID-19 test for a while. Last week, the San Diego-based company received $561,330 from the Biomedical Advanced Research and Development Authority for the development and commercialization of the test.

The company already sells commercial tests for influenza and RSV that run on its system.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.